Lakeway, TX -- (SBWIRE) -- 02/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) shares jumped 2.62% and closed at $74.74 in the last trading session. Thestreet reiterated their hold rating on shares of Onyx Pharmaceuticals (NASDAQ: ONXX) in a research note issued to investors on Feb. 12.
Additionally, the company announced that it will report financial results for the fourth quarter and full year 2012 ended December 31, 2012 after market closes on Thursday, February 21, 2013.
How Should Investors Trade ONXX After The Latest Earnings Report? Find Out Here
Genpact Limited (NYSE:G) shares gained 2.62% to $16.87. The company, on Feb. 7, reported that its fourth-quarter net income declined to 53.4 million or $0.23 per share, from $61.1 million or $0.27 per share in the comparable quarter last year. Adjusted income from operations was $83.9 million, up from $77.1 million in the year-ago quarter. Adjusted earnings for the latest fourth quarter dropped to $0.25 per share from $0.32 per share in the prior year quarter. Analysts expected the company to report earnings of $0.24 per share for the quarter. Meanwhile, revenues rose by 14.7 percent to $507.7 million from $442.7 million in the prior year, while nine analysts had consensus revenue estimate of $502.62 million for the quarter.
Is G a Buy After The Solid Earnings? Get Free Trend Analysis Here
Realogy Holdings Corp (NYSE:RLGY) shares increased 2.58% to $46.48 in yesterday’s session. The company will release its full year 2012 financial results for the year ended December 31, 2012 at 7:00 a.m. (EST) on Monday, February 25, 2013.
Additionally, the company announced this week its intention to refinance its senior secured credit facility. Subject to market conditions, Realogy is seeking to refinance its $1.822 billion extended term loan facility and increase its revolving credit facility to up to $600 million from $363 million while extending the maturities beyond their current October 2016 and April 2016 maturity dates, respectively.
How Should Investors Trade RLGY After The Recent Movement? Find Out Here
Generex Biotechnology Corporation (OTC:GNBT) shares climbed 3.02% to $0.0410. The company, on Jan. 31, explained the potential of the technology platform used as the basis for its novel breast cancer immunotherapy product AE37. AE37 is currently in late Phase IIb clinical development and has garnered considerable attention based upon favourable results from interim analysis of its controlled, randomized, and blinded trial in women with early stage breast cancer.
Get Latest News, Updates and Reports For Free On GNBT Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)